デフォルト表紙
市場調査レポート
商品コード
1460734

生体触媒の世界市場:市場規模・シェア分析 (原料別・種類別・用途別)、産業需要の予測 (~2030年)

Biocatalyst Market Size and Share Analysis by Source, Type, Application - Global Industry Demand Forecast to 2030

出版日: | 発行: Prescient & Strategic Intelligence | ページ情報: 英文 240 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
生体触媒の世界市場:市場規模・シェア分析 (原料別・種類別・用途別)、産業需要の予測 (~2030年)
出版日: 2024年03月01日
発行: Prescient & Strategic Intelligence
ページ情報: 英文 240 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

市場概要

世界の生体触媒 (バイオ触媒) の市場規模は、2023年に6億760万米ドルで、2024年から2030年にかけてCAGR 6.3%で成長し、2030年には9億2,520万米ドルに達すると予測されています。

生物由来の生体触媒は、各種の産業分野において、一般的に石油由来の合成触媒に代わる環境に優しい触媒です。特殊化学品と汎用化学品の両方の生産において重要な役割を果たしています。

生物触媒の最も顕著な工業的応用は、医薬品の香りや芳香に使用される立体特異的化合物 (キラル化合物とも呼ばれる) です。キラルな水酸基を持つ中化合物は、医薬品に使用される様々な化学物質の製造に使用されるだけでなく、様々な原薬にも存在します。

主要な洞察

種類別では、2023年にヒドロラーゼは業界収益の40%を占め、リパーゼ、アミダーゼ、プロテアーゼなどの多様な生物学的手順において不可欠です。

用途別では、2023年に食品・飲料カテゴリーが25%の収益シェアを占めていました。

原料別では、2023年に微生物が2億米ドル分の収益となり、著しい成長を示すと予測されています。

地域別では、2023年には北米地域が収益ベースで最大の地域として浮上し、大幅な発展軌道を維持すると予測されています。

当レポートでは、世界の生体触媒の市場について分析し、市場の基本構造・最新情勢や主な促進・抑制要因、世界全体および地域別・主要国の市場規模の動向見通し (数量・金額ベース、2017~2030年)、原料別・種類別・用途別の詳細動向、現在の市場競争の状況、主要企業のプロファイルなどを調査しております。

目次

第1章 調査範囲

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場指標

第5章 業界の展望

  • 市場力学
    • 動向
    • 促進要因
    • 抑制要因/課題
    • 促進要因/抑制要因の影響分析
  • 新型コロナウイルス感染症 (COVID-19) の影響
  • ポーターのファイブフォース分析

第6章 世界市場

  • 概要
  • 市場規模:原料別 (2017~2030年)
  • 市場収益:原料別 (2017~2030年)
  • 市場規模:種類別 (2017~2030年)
  • 市場収益:種類別 (2017~2030年)
  • 市場規模:用途別 (2017~2030年)
  • 市場収益:用途別 (2017~2030年)
  • 市場規模:地域別 (2017~2030年)
  • 市場収益:地域別 (2017~2030年)

第7章 北米市場

  • 概要
  • 市場規模:原料別 (2017~2030年)
  • 市場収益:原料別 (2017~2030年)
  • 市場規模:種類別 (2017~2030年)
  • 市場収益:種類別 (2017~2030年)
  • 市場規模:用途別 (2017~2030年)
  • 市場収益:用途別 (2017~2030年)
  • 市場規模:地域別 (2017~2030年)
  • 市場収益:地域別 (2017~2030年)

第8章 欧州市場

第9章 アジア太平洋市場

第10章 ラテンアメリカ市場

第11章 中東・アフリカ市場

第12章 米国市場

  • 概要
  • 市場規模:原料別 (2017~2030年)
  • 市場収益:原料別 (2017~2030年)
  • 市場規模:種類別 (2017~2030年)
  • 市場収益:種類別 (2017~2030年)
  • 市場規模:用途別 (2017~2030年)
  • 市場収益:用途別 (2017~2030年)

第13章 カナダ市場

第14章 ドイツ市場

第15章 フランス市場

第16章 英国市場

第17章 イタリア市場

第18章 スペイン市場

第19章 日本市場

第20章 中国市場

第21章 インド市場

第22章 オーストラリア市場

第23章 韓国市場

第24章 ブラジル市場

第25章 メキシコ市場

第26章 サウジアラビア市場

第27章 南アフリカ市場

第28章 アラブ首長国連邦 (UAE) 市場

第29章 競合情勢

  • 市場参入企業とその提供製品/サービスの一覧
  • 主要企業の競合ベンチマーク
  • 主要企業の製品ベンチマーク
  • 最近の戦略展開状況

第30章 企業プロファイル

  • Codexis Inc.
  • DuPont de Nemours Inc.
  • Koninklijke DSM N.V.
  • Novozymes
  • BASF SE
  • Amano Enzyme Inc.
  • Biocatalysts Limited
  • AB Enzymes GmbH
  • Lonza Group Ltd.
  • Chr. Hansen Holding A/S

第31章 付録

目次
Product Code: 12830

Market Overview

In 2023, the biocatalyst market was valued at USD 607.6 million and is projected to grow at a CAGR of 6.3% from 2024 to 2030, reaching USD 925.2 million by 2030.

Biocatalysts sourced from biological origins offer an eco-friendly substitute for synthetic catalysts, commonly derived from petroleum, across various industrial sectors. They play a significant role in producing both specialty and commodity chemicals.

The advancement of cost-effective genetic engineering techniques has significantly contributed to their increased manufacturing. These bio-enzymes enable precise reactions, leading to desired outcomes with minimal waste and fewer by-products, bolstering their appeal in industrial processes.

Biocatalysts are progressively becoming functional in biotransformation procedures, and therefore, they have become significant nearly in all industries, mainly chemicals, and pharmaceuticals. The growth of lucrative and ecological chemoenzymatic processes strongly relies on the extensive accessibility and pertinency of enzymes with high performance, irrespective of ecological conditions.

Biocatalysis guarantees that compound molecules are made with high accuracy while meeting severe quality standards. This adhesive their cruciality in the pharmacological sector, where accurate quality and concentrations are important.

The most prominent industrial applications of biocatalysis are stereospecific compounds (also called chiral compounds) used for pharmaceuticals aromas and fragrances. Chiral hydroxyl moieties medium compounds exist in various APIs as well as they are used in the production of various chemicals for use in pharmaceuticals.

Key Insights

In 2023, hydrolases held 40% of the industry revenue, essential in diverse biological procedures such as lipases, amidases, and proteases.

Hydrolases feature prominently in permitted medications for conditions such as Alzheimer's, diabetes, and communicable diseases.

These enzymes are also used in detergent formulations to eliminate blood and protein stains, guaranteeing clean clothes.

In 2023, the food & beverages category had a 25% revenue share among biocatalyst applications.

Biocatalysts are vital enzymes in food processing and additive production.

Sectors such as brewing, bakery, dairy, meat, beverages, and sugar use bio-enzymes widely.

Biocatalysis is favored because of growing ecological awareness and sustainability requirements, providing advanced effectiveness and safety.

Its sustainability stems from working under mild conditions and decreasing energy use, waste, and by-products.

Constant innovation permits biocatalysis to evolve and fulfill diverse market requirements efficiently.

In 2023, microorganisms contributed USD 0.2 billion to the industry, and the category is projected to showcase significant growth.

Enzymes from microbial sources are lucrative, scalable for wholesale production, and have high enzyme content.

Microbe-based enzymes are strong, quicken reactions efficiently, produce diverse compounds, and provide cost benefits.

In 2023, the North American region arose as the largest revenue contributor to the worldwide biocatalyst industry and is projected to uphold a substantial development trajectory.

This development is mainly propelled by the strong pharmaceutical and food sectors dominant in the region, which cater as major industry drivers.

The United States and Europe comprise the two leading superpowers of the world pharmaceutical industry, with America capturing 49.1% of the market and Europe controlling 23.4% of the global turnover of pharmaceuticals in 2021.

Statics from the European Federation of Pharmaceutical Industries and Associations (EFPIA) reveal the contribution of the United States and Europe was 64.4% and 16.2% respectively, newly drugs launched between 2016 and 2021.

Table of Contents

Chapter 1. Research Scope

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Analysis Period
  • 1.4. Market Size Breakdown by Segments
    • 1.4.1. Market size breakdown, by source
    • 1.4.2. Market size breakdown, by type
    • 1.4.3. Market size breakdown, by application
    • 1.4.4. Market size breakdown, by region
    • 1.4.5. Market size breakdown, by country
  • 1.5. Market Data Reporting Unit
    • 1.5.1. Volume
    • 1.5.2. Value
  • 1.6. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
    • 2.1.1. Paid
    • 2.1.2. Unpaid
    • 2.1.3. P&S Intelligence database
  • 2.2. Primary Research
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Currency Conversion Rates
  • 2.6. Assumptions for the Study
  • 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

  • 5.1. Market Dynamics
    • 5.1.1. Trends
    • 5.1.2. Drivers
    • 5.1.3. Restraints/challenges
    • 5.1.4. Impact analysis of drivers/restraints
  • 5.2. Impact of COVID-19
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Bargaining power of buyers
    • 5.3.2. Bargaining power of suppliers
    • 5.3.3. Threat of new entrants
    • 5.3.4. Intensity of rivalry
    • 5.3.5. Threat of substitutes

Chapter 6. Global Market

  • 6.1. Overview
  • 6.2. Market Volume, by Source (2017-2030)
  • 6.3. Market Revenue, by Source (2017-2030)
  • 6.4. Market Volume, by Type (2017-2030)
  • 6.5. Market Revenue, by Type (2017-2030)
  • 6.6. Market Volume, by Application (2017-2030)
  • 6.7. Market Revenue, by Application (2017-2030)
  • 6.8. Market Volume, by Region (2017-2030)
  • 6.9. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

  • 7.1. Overview
  • 7.2. Market Volume, by Source (2017-2030)
  • 7.3. Market Revenue, by Source (2017-2030)
  • 7.4. Market Volume, by Type (2017-2030)
  • 7.5. Market Revenue, by Type (2017-2030)
  • 7.6. Market Volume, by Application (2017-2030)
  • 7.7. Market Revenue, by Application (2017-2030)
  • 7.8. Market Volume, by Country (2017-2030)
  • 7.9. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

  • 8.1. Overview
  • 8.2. Market Volume, by Source (2017-2030)
  • 8.3. Market Revenue, by Source (2017-2030)
  • 8.4. Market Volume, by Type (2017-2030)
  • 8.5. Market Revenue, by Type (2017-2030)
  • 8.6. Market Volume, by Application (2017-2030)
  • 8.7. Market Revenue, by Application (2017-2030)
  • 8.8. Market Volume, by Country (2017-2030)
  • 8.9. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

  • 9.1. Overview
  • 9.2. Market Volume, by Source (2017-2030)
  • 9.3. Market Revenue, by Source (2017-2030)
  • 9.4. Market Volume, by Type (2017-2030)
  • 9.5. Market Revenue, by Type (2017-2030)
  • 9.6. Market Volume, by Application (2017-2030)
  • 9.7. Market Revenue, by Application (2017-2030)
  • 9.8. Market Volume, by Country (2017-2030)
  • 9.9. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

  • 10.1. Overview
  • 10.2. Market Volume, by Source (2017-2030)
  • 10.3. Market Revenue, by Source (2017-2030)
  • 10.4. Market Volume, by Type (2017-2030)
  • 10.5. Market Revenue, by Type (2017-2030)
  • 10.6. Market Volume, by Application (2017-2030)
  • 10.7. Market Revenue, by Application (2017-2030)
  • 10.8. Market Volume, by Country (2017-2030)
  • 10.9. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

  • 11.1. Overview
  • 11.2. Market Volume, by Source (2017-2030)
  • 11.3. Market Revenue, by Source (2017-2030)
  • 11.4. Market Volume, by Type (2017-2030)
  • 11.5. Market Revenue, by Type (2017-2030)
  • 11.6. Market Volume, by Application (2017-2030)
  • 11.7. Market Revenue, by Application (2017-2030)
  • 11.8. Market Volume, by Country (2017-2030)
  • 11.9. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

  • 12.1. Overview
  • 12.2. Market Volume, by Source (2017-2030)
  • 12.3. Market Revenue, by Source (2017-2030)
  • 12.4. Market Volume, by Type (2017-2030)
  • 12.5. Market Revenue, by Type (2017-2030)
  • 12.6. Market Volume, by Application (2017-2030)
  • 12.7. Market Revenue, by Application (2017-2030)

Chapter 13. Canada Market

  • 13.1. Overview
  • 13.2. Market Volume, by Source (2017-2030)
  • 13.3. Market Revenue, by Source (2017-2030)
  • 13.4. Market Volume, by Type (2017-2030)
  • 13.5. Market Revenue, by Type (2017-2030)
  • 13.6. Market Volume, by Application (2017-2030)
  • 13.7. Market Revenue, by Application (2017-2030)

Chapter 14. Germany Market

  • 14.1. Overview
  • 14.2. Market Volume, by Source (2017-2030)
  • 14.3. Market Revenue, by Source (2017-2030)
  • 14.4. Market Volume, by Type (2017-2030)
  • 14.5. Market Revenue, by Type (2017-2030)
  • 14.6. Market Volume, by Application (2017-2030)
  • 14.7. Market Revenue, by Application (2017-2030)

Chapter 15. France Market

  • 15.1. Overview
  • 15.2. Market Volume, by Source (2017-2030)
  • 15.3. Market Revenue, by Source (2017-2030)
  • 15.4. Market Volume, by Type (2017-2030)
  • 15.5. Market Revenue, by Type (2017-2030)
  • 15.6. Market Volume, by Application (2017-2030)
  • 15.7. Market Revenue, by Application (2017-2030)

Chapter 16. U.K. Market

  • 16.1. Overview
  • 16.2. Market Volume, by Source (2017-2030)
  • 16.3. Market Revenue, by Source (2017-2030)
  • 16.4. Market Volume, by Type (2017-2030)
  • 16.5. Market Revenue, by Type (2017-2030)
  • 16.6. Market Volume, by Application (2017-2030)
  • 16.7. Market Revenue, by Application (2017-2030)

Chapter 17. Italy Market

  • 17.1. Overview
  • 17.2. Market Volume, by Source (2017-2030)
  • 17.3. Market Revenue, by Source (2017-2030)
  • 17.4. Market Volume, by Type (2017-2030)
  • 17.5. Market Revenue, by Type (2017-2030)
  • 17.6. Market Volume, by Application (2017-2030)
  • 17.7. Market Revenue, by Application (2017-2030)

Chapter 18. Spain Market

  • 18.1. Overview
  • 18.2. Market Volume, by Source (2017-2030)
  • 18.3. Market Revenue, by Source (2017-2030)
  • 18.4. Market Volume, by Type (2017-2030)
  • 18.5. Market Revenue, by Type (2017-2030)
  • 18.6. Market Volume, by Application (2017-2030)
  • 18.7. Market Revenue, by Application (2017-2030)

Chapter 19. Japan Market

  • 19.1. Overview
  • 19.2. Market Volume, by Source (2017-2030)
  • 19.3. Market Revenue, by Source (2017-2030)
  • 19.4. Market Volume, by Type (2017-2030)
  • 19.5. Market Revenue, by Type (2017-2030)
  • 19.6. Market Volume, by Application (2017-2030)
  • 19.7. Market Revenue, by Application (2017-2030)

Chapter 20. China Market

  • 20.1. Overview
  • 20.2. Market Volume, by Source (2017-2030)
  • 20.3. Market Revenue, by Source (2017-2030)
  • 20.4. Market Volume, by Type (2017-2030)
  • 20.5. Market Revenue, by Type (2017-2030)
  • 20.6. Market Volume, by Application (2017-2030)
  • 20.7. Market Revenue, by Application (2017-2030)

Chapter 21. India Market

  • 21.1. Overview
  • 21.2. Market Volume, by Source (2017-2030)
  • 21.3. Market Revenue, by Source (2017-2030)
  • 21.4. Market Volume, by Type (2017-2030)
  • 21.5. Market Revenue, by Type (2017-2030)
  • 21.6. Market Volume, by Application (2017-2030)
  • 21.7. Market Revenue, by Application (2017-2030)

Chapter 22. Australia Market

  • 22.1. Overview
  • 22.2. Market Volume, by Source (2017-2030)
  • 22.3. Market Revenue, by Source (2017-2030)
  • 22.4. Market Volume, by Type (2017-2030)
  • 22.5. Market Revenue, by Type (2017-2030)
  • 22.6. Market Volume, by Application (2017-2030)
  • 22.7. Market Revenue, by Application (2017-2030)

Chapter 23. South Korea Market

  • 23.1. Overview
  • 23.2. Market Volume, by Source (2017-2030)
  • 23.3. Market Revenue, by Source (2017-2030)
  • 23.4. Market Volume, by Type (2017-2030)
  • 23.5. Market Revenue, by Type (2017-2030)
  • 23.6. Market Volume, by Application (2017-2030)
  • 23.7. Market Revenue, by Application (2017-2030)

Chapter 24. Brazil Market

  • 24.1. Overview
  • 24.2. Market Volume, by Source (2017-2030)
  • 24.3. Market Revenue, by Source (2017-2030)
  • 24.4. Market Volume, by Type (2017-2030)
  • 24.5. Market Revenue, by Type (2017-2030)
  • 24.6. Market Volume, by Application (2017-2030)
  • 24.7. Market Revenue, by Application (2017-2030)

Chapter 25. Mexico Market

  • 25.1. Overview
  • 25.2. Market Volume, by Source (2017-2030)
  • 25.3. Market Revenue, by Source (2017-2030)
  • 25.4. Market Volume, by Type (2017-2030)
  • 25.5. Market Revenue, by Type (2017-2030)
  • 25.6. Market Volume, by Application (2017-2030)
  • 25.7. Market Revenue, by Application (2017-2030)

Chapter 26. Saudi Arabia Market

  • 26.1. Overview
  • 26.2. Market Volume, by Source (2017-2030)
  • 26.3. Market Revenue, by Source (2017-2030)
  • 26.4. Market Volume, by Type (2017-2030)
  • 26.5. Market Revenue, by Type (2017-2030)
  • 26.6. Market Volume, by Application (2017-2030)
  • 26.7. Market Revenue, by Application (2017-2030)

Chapter 27. South Africa Market

  • 27.1. Overview
  • 27.2. Market Volume, by Source (2017-2030)
  • 27.3. Market Revenue, by Source (2017-2030)
  • 27.4. Market Volume, by Type (2017-2030)
  • 27.5. Market Revenue, by Type (2017-2030)
  • 27.6. Market Volume, by Application (2017-2030)
  • 27.7. Market Revenue, by Application (2017-2030)

Chapter 28. U.A.E. Market

  • 28.1. Overview
  • 28.2. Market Volume, by Source (2017-2030)
  • 28.3. Market Revenue, by Source (2017-2030)
  • 28.4. Market Volume, by Type (2017-2030)
  • 28.5. Market Revenue, by Type (2017-2030)
  • 28.6. Market Volume, by Application (2017-2030)
  • 28.7. Market Revenue, by Application (2017-2030)

Chapter 29. Competitive Landscape

  • 29.1. List of Market Players and their Offerings
  • 29.2. Competitive Benchmarking of Key Players
  • 29.3. Product Benchmarking of Key Players
  • 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

  • 30.1. Codexis Inc.
    • 30.1.1. Business overview
    • 30.1.2. Product and service offerings
    • 30.1.3. Key financial summary
  • 30.2. DuPont de Nemours Inc.
    • 30.2.1. Business overview
    • 30.2.2. Product and service offerings
    • 30.2.3. Key financial summary
  • 30.3. Koninklijke DSM N.V.
    • 30.3.1. Business overview
    • 30.3.2. Product and service offerings
    • 30.3.3. Key financial summary
  • 30.4. Novozymes
    • 30.4.1. Business overview
    • 30.4.2. Product and service offerings
    • 30.4.3. Key financial summary
  • 30.5. BASF SE
    • 30.5.1. Business overview
    • 30.5.2. Product and service offerings
    • 30.5.3. Key financial summary
  • 30.6. Amano Enzyme Inc.
    • 30.6.1. Business overview
    • 30.6.2. Product and service offerings
    • 30.6.3. Key financial summary
  • 30.7. Biocatalysts Limited
    • 30.7.1. Business overview
    • 30.7.2. Product and service offerings
    • 30.7.3. Key financial summary
  • 30.8. AB Enzymes GmbH
    • 30.8.1. Business overview
    • 30.8.2. Product and service offerings
    • 30.8.3. Key financial summary
  • 30.9. Lonza Group Ltd.
    • 30.9.1. Business overview
    • 30.9.2. Product and service offerings
    • 30.9.3. Key financial summary
  • 30.10. Chr. Hansen Holding A/S
    • 30.10.1. Business overview
    • 30.10.2. Product and service offerings
    • 30.10.3. Key financial summary

Chapter 31. Appendix

  • 31.1. Abbreviations
  • 31.2. Sources and References
  • 31.3. Related Reports